business

Edgewise Therapeutics, Inc. (EWTX) Price Target Raised to $59 on Positive HCM Trial Data

Yahoo Finance · Jun 25, 2026, 12:41 PM · Also reported by 4 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Rosenblatt raises Qualcomm stock price target to $265 on data center growth Investing.com Cantor raises Qualcomm stock price target to $220 on data center goals MacRumors Apple Just Raised the Price of the MacBook Neo Investing.com Canaccord lowers Worthington Industries stock price target on Q4 miss

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Edgewise Therapeutics, Inc. (EWTX) Price Target Raised to $59 on Positive HCM Trial Data

Also covered by

More in business